X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Piramal Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs TEVA PHARMA (Israel) - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   TEVA PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
TEVA PHARMA
Dec-13
PIRAMAL ENTERPRISES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,3032,992-   
Low Rs1,7972,599-   
Sales per share (Unadj.) Rs716.51,717.3-  
Earnings per share (Unadj.) Rs79.7107.3-  
Cash flow per share (Unadj.) Rs107.9246.1-  
Dividends per share (Unadj.) Rs28.0093.91-  
Dividend yield (eoy) %1.13.4 32.7%  
Book value per share (Unadj.) Rs1,477.51,907.6-  
Shares outstanding (eoy) m184.45848.00-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.61.6 218.6%   
Avg P/E ratio x32.026.1 122.7%  
P/CF ratio (eoy) x23.611.4 208.0%  
Price / Book Value ratio x1.71.5 117.7%  
Dividend payout %35.187.5 40.1%   
Avg Mkt Cap Rs m470,2922,370,932 19.8%   
No. of employees `0007.844.9 17.4%   
Total wages/salary Rs m22,5040-   
Avg. sales/employee Rs Th16,899.432,402.1 52.2%   
Avg. wages/employee Rs Th2,877.70-   
Avg. net profit/employee Rs Th1,879.92,024.1 92.9%   
INCOME DATA
Net Sales Rs m132,1531,456,311 9.1%  
Other income Rs m3,1280-   
Total revenues Rs m135,2811,456,311 9.3%   
Gross profit Rs m66,290398,811 16.6%  
Depreciation Rs m5,202117,715 4.4%   
Interest Rs m44,09728,604 154.2%   
Profit before tax Rs m20,119252,492 8.0%   
Minority Interest Rs m3,1941,147 278.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-165,747 0.0%   
Tax Rs m8,611-3,083 -279.3%   
Profit after tax Rs m14,70190,975 16.2%  
Gross profit margin %50.227.4 183.2%  
Effective tax rate %42.8-1.2 -3,505.8%   
Net profit margin %11.16.2 178.1%  
BALANCE SHEET DATA
Current assets Rs m122,742983,587 12.5%   
Current liabilities Rs m310,810857,771 36.2%   
Net working cap to sales %-142.38.6 -1,647.2%  
Current ratio x0.41.1 34.4%  
Inventory Days Days2391 25.4%  
Debtors Days Days3996 40.5%  
Net fixed assets Rs m116,904475,663 24.6%   
Share capital Rs m3693,585 10.3%   
"Free" reserves Rs m272,1610-   
Net worth Rs m272,5301,617,685 16.8%   
Long term debt Rs m270,196744,644 36.3%   
Total assets Rs m856,2613,328,137 25.7%  
Interest coverage x1.59.8 14.8%   
Debt to equity ratio x1.00.5 215.4%  
Sales to assets ratio x0.20.4 35.3%   
Return on assets %6.93.6 191.1%  
Return on equity %5.45.6 95.9%  
Return on capital %12.44.9 251.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,3120-   
CASH FLOW
From Operations Rs m-115,975232,061 -50.0%  
From Investments Rs m-8,265-82,228 10.1%  
From Financial Activity Rs m107,525-278,372 -38.6%  
Net Cashflow Rs m-16,650-128,540 13.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.69 Rs / USD

Compare PIRAMAL ENTERPRISES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare PIRAMAL ENTERPRISES With: TTK HEALTHCARE  PFIZER  J.B.CHEMICALS  SHASUN PHARMA  WYETH LTD  



Today's Market

Of Falling Stocks, Tumbling Rupee and Weakening Economy(Podcast)

Another week of slowdown in the markets over fears of a looming slowdown in the domestic and global economy continue.

Related Views On News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

This 60-Year Old Smallcap Company Could Be Our Next Recommendation (The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Interest Rates Are Low. Buy Solid Dividend Stocks Instead (The 5 Minute Wrapup)

Aug 13, 2019

The dividends paid by these stocks are helpful when interest rates are falling.

Smallcaps that Will Outperform in the Market Rebound (Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

My Top 3 Dividend Stocks to Buy Now (Profit Hunter)

Aug 19, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Chandrayaan 2 Heads to the Moon and It's Good News for These Stocks (The 5 Minute Wrapup)

Aug 14, 2019

Why investors should take note of India's advantage as a low cost satellite launcher...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 23, 2019 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS